{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:40:18Z","timestamp":1695120018186},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>A 3-year-old boy was clinically diagnosed with Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis. We identified EBV-infected CD8-positive T-lymphocytes by cytologic double staining of the peripheral blood for EBV-encoded small RNA and cell surface markers. The patient was subsequently administered immunosuppressive therapy with a reduced dose of etoposide because of previous organ damage. EBV clearance was confirmed by serial quantification of cell-fractionated EBV-DNA, whereas EBV-DNA persisted in the plasma for 18 weeks. Immunochemotherapy with low-dose etoposide combined with serial viral load monitoring is a potential therapeutic option for severe EBV-hemophagocytic lymphohistiocytosis cases with organ damage.<\/jats:p>","DOI":"10.1097\/mph.0000000000001647","type":"journal-article","created":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T23:37:18Z","timestamp":1574033838000},"page":"e756-e758","source":"Crossref","is-referenced-by-count":2,"title":["A Rapid Cytologic Double Staining of Epstein-Barr Virus\u2013encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus\u2013associated Hemophagocytic Lymphohistiocytosis"],"prefix":"10.1097","volume":"42","author":[{"given":"Natsuki","family":"Takahashi","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Kudo","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Shinshu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Anatomic Pathology, Hirosaki University Graduate School of Medicine, Hirosaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kamio","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kurose","sequence":"additional","affiliation":[{"name":"Anatomic Pathology, Hirosaki University Graduate School of Medicine, Hirosaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Yanagisawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Shinshu University"},{"name":"Division of Blood Transfusion, Shinshu University Hospital, Matsumoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Shinshu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","article-title":"Clinical features and treatment strategies of Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"44","author":"Imashuku","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MPH.0b013e3181f84a52","article-title":"Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010","volume":"33","author":"Imashuku","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/605610","article-title":"Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases","volume":"200","author":"Kimura","year":"2009","journal-title":"J Infect Dis"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","article-title":"Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"98","author":"Kasahara","year":"2001","journal-title":"Blood"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fped.2018.00327","article-title":"Cytologic analysis of Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative diseases","volume":"6","author":"Yachie","year":"2018","journal-title":"Front Pediatr"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MPH.0000000000001262","article-title":"Significance of molecular monitoring of T cells for the decision of treatment strategy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"41","author":"Saito","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/pbc.24980","article-title":"Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group","volume":"61","author":"Kogawa","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12185-018-02572-z","article-title":"Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan","volume":"109","author":"Yanagisawa","year":"2019","journal-title":"Int J Hematol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12185-019-02612-2","article-title":"Factors predicting the recurrence of Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol","volume":"109","author":"Yanagisawa","year":"2019","journal-title":"Int J Hematol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF02982023","article-title":"Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"75","author":"Imashuku","year":"2002","journal-title":"Int J Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T06:15:03Z","timestamp":1695017703000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001647","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,14]]}}}